Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.
Alimera Announces Multiple Presentations Highlighting ILUVIEN And YUTIQ Data At Retina Society Annual Congress
Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer,
